beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Citation
R. Vassar et al., beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, SCIENCE, 286(5440), 1999, pp. 735-741
Citations number
32
Categorie Soggetti
Multidisciplinary,Multidisciplinary,Multidisciplinary
Journal title
SCIENCE
ISSN journal
00368075 → ACNP
Volume
286
Issue
5440
Year of publication
1999
Pages
735 - 741
Database
ISI
SICI code
0036-8075(19991022)286:5440<735:BCOAAP>2.0.ZU;2-J
Abstract
Cerebral deposition of amyloid beta peptide (A beta) is an early and critic al feature of Alzheimer's disease. A beta generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: beta-secretase and gamma-secretase. These proteases are prime therapeutic t argets. A transmembrane aspartic protease with all the known characteristic s of beta-secretase was cloned and characterized. Overexpression of this pr otease, termed BACE (for beta-site APP-cleaving enzyme) increased the amoun t of beta-secretase cleavage products, and these were cleaved exactly and o nly at known beta-secretase positions. Antisense inhibition of endogenous B ACE messenger RNA decreased the amount of beta-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same seq uence specificity as beta-secretase. Finally, the expression pattern and su bcellular Localization of BACE were consistent with that expected for beta- secretase. Future development of BACE inhibitors may prove beneficial for t he treatment of Alzheimer's disease.